ArrowMark Colorado Holdings LLC
Source: SEC Form 13F · as of Mar 2026ArrowMark Colorado Holdings LLC holds 24 biotech & pharma companies tracked by BioSniper, totaling $213.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$213.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Definium Therapeutics Inc. (DFTX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| DFTXDefinium Therapeutics Inc. | 1,594,717 | $30.1M |
| MAZEMaze Therapeutics, Inc. | 767,383 | $22.9M |
| NUVLNuvalent, Inc. | 186,850 | $19.1M |
| KNSAKiniksa Pharmaceuticals International, plc | 316,956 | $15.3M |
| TNGXTango Therapeutics, Inc. | 708,385 | $14.8M |
| ABCLAbCellera Biologics Inc. | 4,105,095 | $14.3M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 403,590 | $13.7M |
| ZBIOZenas BioPharma, Inc. | 658,909 | $12.9M |
| ORICOric Pharmaceuticals, Inc. | 960,517 | $12.2M |
| NGNENeurogene Inc. | 524,796 | $10.6M |
| APGEApogee Therapeutics, Inc. | 109,410 | $9.2M |
| GPCRStructure Therapeutics Inc. | 188,195 | $9.1M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 259,524 | $8.3M |
| NRIXNurix Therapeutics, Inc. | 314,762 | $4.9M |
| CMPXCompass Therapeutics, Inc. | 514,793 | $2.7M |
| PCVXVaxcyte, Inc. | 40,000 | $2.3M |
| SANASana Biotechnology, Inc. | 685,125 | $2.0M |
| FDMT4D Molecular Therapeutics, Inc. | 202,864 | $1.9M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 20,788 | $1.7M |
| IMVTImmunovant, Inc. | 70,000 | $1.7M |
| SRZNSurrozen Inc. | 55,123 | $1.6M |
| VKTXViking Therapeutics, Inc. | 34,878 | $1.1M |
| CLDXCelldex Therapeutics, Inc. | 25,000 | $793K |
| PLRXPLIANT THERAPEUTICS, INC. | 281,189 | $354K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.